THOMAS A. ALBRIGHT
Tom has 35 years of experience in the field of pharmaceutical, biologic, device and aesthetic-related sales, marketing and general management roles. He currently serves as the CEO of Recros Medica and Chairman and CEO of Andrew Technologies. Prior to that, he was president of the topical aesthetic division at Syneron Medical, Head of North American marketing at Nobel Biocare. His medical aesthetic experience commenced with Allergan (2000 – 2008), where he led the launch of BOTOX® Cosmetic and the commercial development of Latisse®. He was also the alliance manager for the collaboration between Allergan and GlaxoSmithKline in China, Japan, and the US. In 1983, he commenced his career in healthcare with the Parke-Davis division of Warner Lambert, where he held sales and marketing leadership roles, including the 1997 launch of Lipitor®, among other brands. Tom has a BS in biology from The Citadel and an MBA in marketing from Mercer University.